DEA Archived Press Releases

Press Releases before January 20, 2025
357 Results - Showing 71 to 80
PRESS RELEASE

Physician Charged with Distributing a Controlled Substance Appears in Federal Court

CHARLOTTE, N.C. – A North Carolina physician appeared before U.S. Magistrate Judge Susan C. Rodriguez this morning on charges related to the alleged unlawful distribution of a controlled substance, announced Dena J. King, U.S. Attorney for the Western District of North Carolina. A criminal indictment charging Henry Ronald Emery, Jr...
PRESS RELEASE

Former Chief Operating Officer of Area Pain Clinics Indicted

CHARLOTTESVLLE, Va. – A federal grand jury returned an indictment this week charging the former chief operating officer of area pain clinics with three conspiracy counts for her alleged involvement in health care fraud and illegal drug distribution. Jennifer Ann “Jen” Adams, 50, of Mount Pleasant, South Carolina, is charged...
PRESS RELEASE

New Hampshire Doctor Indicted for Unlawfully Distributing Opioids and Benzodiazepines

CONCORD, N.H. – A doctor practicing in the north country of New Hampshire was indicted in connection with his unlawful distribution of opioids and benzodiazepines, U.S. Attorney Jane E. Young announces. Robert G. Soucy Jr., D.O., 70, of Columbia, New Hampshire, was indicted on 12 counts of distribution of controlled...
PRESS RELEASE

Pharmacy Agrees to Pay $250,000 for Improperly Distributing Prescriptions

KANSAS CITY, Kan. - A Kansas City, Kansas, company entered into a civil settlement agreement with the federal government to pay $250,000 to resolve allegations that a retail pharmacy it owns violated the civil provisions of the Controlled Substances Act. Four B. Corporation, doing business as Balls Food Stores, owns...
PRESS RELEASE

Former Auburn Physician Pays $135,000 and Forfeits DEA Registration, for Overprescribing Controlled Substances

SYRACUSE, NEW YORK – Dr. Jang Boo Chi, formerly a physician in Auburn, and his medical practice, Jang Boo Chi M.D. P.C., have agreed to pay the United States $135,000 in civil penalties for overprescribing opioids and other controlled substances in dangerous combinations. United States Attorney Carla B. Freedman, and...
PRESS RELEASE

Former Connecticut Residents Charged with Operating Websites to Illegally Sell Misbranded and Unapproved Drugs

GLASTONBURY, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, has announced that a federal grand jury in New Haven has returned an indictment charging RYAN FIELDS, 49, and LISA MAHAN, 53, of Port Neches, Texas, formerly of Glastonbury, Connecticut, with federal offenses for illegally selling...
PRESS RELEASE

Previously Convicted Felon Indicted for Narcotics and Firearms Offenses

BOSTON – A Methuen man has been indicted by a federal grand jury in Boston for allegedly trafficking counterfeit prescription pills containing fentanyl and methamphetamine, unlawfully possessing firearms and ammunition and using a firearm in relation of a drug trafficking offense. Shawn Hart, 45, was charged with one count of...
PRESS RELEASE

West Seneca Woman Pleads Guilty to Drug Possession

BUFFALO, N.Y.-U.S. Attorney Trini E. Ross announced today that Kiara Hurd, 20, of West Seneca, pleaded guilty before U.S. District Judge Lawrence J. Vilardo to possession with intent to distribute oxycodone, which carries a maximum penalty of 20 years in prison and a $1,000,000 fine. Assistant U.S. Attorney Louis A...
PRESS RELEASE

CA Attorney General Bonta Announces Arrest of Santa Clara Doctor for Illegal Opioid Prescription Scheme

SANTA CLARA, Calif. — California Attorney General Rob Bonta today announced the arrest of and filing of charges against Dr. Arash Padidar, a Santa Clara County doctor accused of illegally prescribing opioids to patients. The arrest and charges are the result of an investigation into an alleged two-years-long illegal prescription...
PRESS RELEASE

DEA Hosts Public Listening Sessions on Telemedicine Regulations

WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available...